Dermablend announced the new Quick-Fix Illuminator, a multipurpose concealer and highlighter that brightens the complexion of the skin with the click of a pen.

Health and wellness products retailer GNC is sponsoring a 12-week effort to encourage consumers to transform eating and exercise habits for long-term weight management, the company said.

Hamacher Resource Group will present a session about pharmacy layout, design and OTC merchandising principles to first-year students at Campbell University's pharmacy school, the retail consumer healthcare industry market research firm said Wednesday.

The National Community Pharmacists Association joined the North Dakota Pharmacy Association in support of a pharmacy benefit manager transparency bill that was passed by the state assembly by a vote of 93-0 on Feb. 25.

Acura Pharmaceuticals announced that its next-generation pseudoephedrine with abuse-deterrent technology will now be stocked by North Carolina's Kerr Drug.

Prescription-only pseudoephedrine laws result in well more than $278 million in additional burdens to taxpayers, according to a study published by Matrix Global Advisors.

More Americans want technology to play a bigger role in the healthcare system, The Atlantic reported, as part of a survey the magazine conducted in collaboration with GlaxoSmithKline.

Duck Tape is heading to the runway this Thursday on Lifetime’s “Project Runway,” as season 11’s aspiring designers face the “Unconventional Materials Challenge,” a competition in every season that challenges them to create high-fashion clothing from something other than fabric.

Drug maker Actavis is challenging the patent for a drug used to treat testosterone deficiency or absence in men, the company said.

Chummies, an innovative friendship bracelet, hit the market on Tuesday. The silicone, latex-free interlocking bracelets are sold in pairs and can be pulled apart to give to various close friends, or "chums."

Walgreens' February sales fell short of analyst projections due to a sharper impact from generic drug introductions.

The stakes are high in a case involving generic drug maker Actavis and the Federal Trade Commission that will soon go before the Supreme Court, the head of a generic drug industry lobbying group said in a conference call with reporters Tuesday.